+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Effects of Tumor Necrosis Factor Alpha on the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Keratoconus Fibroblasts



Effects of Tumor Necrosis Factor Alpha on the Expression of Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in Keratoconus Fibroblasts



Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 33(6): 1139-1144



The aim of this article is to study the effect of tumor necrosis factor alpha(TNF-α)on the expression of matrix metalloproteinases(MMPs)and tissue inhibitors of matrix metalloproteinases(TIMPs)in keratoconus fibroblasts in vitro.Normal cornea and keratoconus fibroblasts were extracted using enzyme digestion method and were cultured in the medium containing TNF-α(0,10 and 100ng/mL).The expression of MMPs proteins in the supernatant of corneal fibroblasts and the expression of TIMPs in the normal cornea and keratoconus fibroblasts were detected by Western blot and real-time quantitative polymerase chain reaction respectively.The active form of MMP1 could be detected in the supernatant of keratoconus fibroblasts and upregulated by TNF-α.TNF-αcould increase the protein expression of MMP2,MMP3,MMP9 in the supernatant of keratoconus fibroblasts and decrease the gene expression of TIMP1,TIMP2 in keratoconus fibroblasts.The increased MMPs and the decreased TIMPs can increase the degradation of the extracellular matrix.TNF-αmay play an important role in the occurrence and development of keratoconus by regulating the expression of MMPs/TIMPs.

(PDF emailed within 1 workday: $29.90)

Accession: 060653493

Download citation: RISBibTeXText

PMID: 29714979


Related references

Effects of tumor necrosis factor-alpha on the synthesis of DNA, the secretion of matrix metalloproteinases/tissue inhibitors of metalloproteinases, and the activity of invasive migration in cultured vascular smooth muscle cells. Journal of Health Science 48(4): 354-358, 2002

Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Experimental Gerontology 31(1-2): 207-223, 1996

Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. Febs Letters 269(1): 93-95, 1990

Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts. Journal of Urology 179(6): 2447-2455, 2008

Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arteriosclerosis, Thrombosis, and Vascular Biology 17(3): 475-482, 1997

The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19(14): 633-635, 2005

Effects of interleukin-1 on the production of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human ligament fibroblasts. Aichi-Gakuin Journal of Dental Science 33(1): 1-17, 1995

Hydrocortisone affects the expression of matrix metalloproteinases (MMP-1, -2, -3, -7, and -11) and tissue inhibitor of matrix metalloproteinases (TIMP-1) in human gingival fibroblasts. Journal of Periodontology 78(7): 1309-1315, 2007

Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis. Experimental Nephrology 3(2): 88-89, 1995

Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Archives Of Dermatological Research. 289(10): 567-572, 1997

Distribution pattern of matrix metalloproteinases 1, 2, 3, and 9, tissue inhibitors of matrix metalloproteinases 1 and 2, and alpha 2-macroglobulin in cases of generalized AA- and AL amyloidosis. Virchows Archiv 437(5): 521-527, 2001

Differential expression of matrix metalloproteinases 2 and 9 by glial Muller cells: Response to soluble and extracellular matrix-bound tumor necrosis factor-alpha. American Journal of Pathology 160(5): 1847-1855, 2002

Endovascular treatment of aneurysms: healing mechanisms in a Swine model are associated with increased expression of matrix metalloproteinases, vascular cell adhesion molecule-1, and vascular endothelial growth factor, and decreased expression of tissue inhibitors of matrix metalloproteinases. Ajnr. American Journal of Neuroradiology 28(5): 849-856, 2007

Human aqueous humor levels of transforming growth factor-β2: Association with matrix metalloproteinases/tissue inhibitors of matrix metalloproteinases. Biomedical Reports 7(6): 573-578, 2017

Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by basic fibroblast growth factor and dexamethasone in periodontal ligament cells. Journal of Periodontal Research 44(6): 794-802, 2010